---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-260863"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2025-10-31T23:59:59+00:00"
generated_at: "2026-05-17T01:07:08.063590+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Chemours adopts new executive severance policy with 2.0x multiplier for CEO

## Summary
- CEO severance: 2.0x sum of base salary, target annual incentive, and annualized health care subsidy; other execs 1.0x.
- Payable on involuntary termination without Cause or resignation for Good Reason; requires signed release of claims.
- Existing change-in-control agreements and equity award terms remain in effect; policy does not supersede them.
- Policy effective October 28, 2025; administered by Board or Compensation Committee; amendment requires 12-month notice.

## SEC filing metadata
- accession: 0001193125-25-260863
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2025-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/0001193125-25-260863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/cc-20251028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-260863
- JSON: https://secwatch.observer/filing/0001193125-25-260863.json
- Plain text: https://secwatch.observer/filing/0001193125-25-260863.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.